631 related articles for article (PubMed ID: 32921250)
1. Hypervirulent
Liu C; Du P; Xiao N; Ji F; Russo TA; Guo J
Virulence; 2020 Dec; 11(1):1215-1224. PubMed ID: 32921250
[TBL] [Abstract][Full Text] [Related]
2. Whole genome analysis of hypervirulent Klebsiella pneumoniae isolates from community and hospital acquired bloodstream infection.
Shankar C; Veeraraghavan B; Nabarro LEB; Ravi R; Ragupathi NKD; Rupali P
BMC Microbiol; 2018 Jan; 18(1):6. PubMed ID: 29433440
[TBL] [Abstract][Full Text] [Related]
3. Antimicrobial Resistance and Pathogenicity Determination of Community-Acquired Hypervirulent
Gao Q; Shen Z; Qin J; Liu Y; Li M
Microb Drug Resist; 2020 Oct; 26(10):1195-1200. PubMed ID: 32354302
[TBL] [Abstract][Full Text] [Related]
4. Identification of Biomarkers for Differentiation of Hypervirulent Klebsiella pneumoniae from Classical K. pneumoniae.
Russo TA; Olson R; Fang CT; Stoesser N; Miller M; MacDonald U; Hutson A; Barker JH; La Hoz RM; Johnson JR
J Clin Microbiol; 2018 Sep; 56(9):. PubMed ID: 29925642
[TBL] [Abstract][Full Text] [Related]
5. Risk factors and clinical outcomes of hypervirulent Klebsiella pneumoniae induced bloodstream infections.
Li J; Ren J; Wang W; Wang G; Gu G; Wu X; Wang Y; Huang M; Li J
Eur J Clin Microbiol Infect Dis; 2018 Apr; 37(4):679-689. PubMed ID: 29238932
[TBL] [Abstract][Full Text] [Related]
6. Distribution, characterization, and antibiotic resistance of hypervirulent Klebsiella pneumoniae isolates in a Chinese population with asymptomatic bacteriuria.
Li J; Li Y; Tang M; Xia F; Min C; Hu Y; Wang H; Zhang J; Zou M
BMC Microbiol; 2022 Jan; 22(1):29. PubMed ID: 35042478
[TBL] [Abstract][Full Text] [Related]
7. Clinical and Molecular Characteristics of Klebsiella pneumoniae Isolates Causing Bloodstream Infections in Japan: Occurrence of Hypervirulent Infections in Health Care.
Harada S; Aoki K; Yamamoto S; Ishii Y; Sekiya N; Kurai H; Furukawa K; Doi A; Tochitani K; Kubo K; Yamaguchi Y; Narita M; Kamiyama S; Suzuki J; Fukuchi T; Gu Y; Okinaka K; Shiiki S; Hayakawa K; Tachikawa N; Kasahara K; Nakamura T; Yokota K; Komatsu M; Takamiya M; Tateda K; Doi Y
J Clin Microbiol; 2019 Nov; 57(11):. PubMed ID: 31434721
[TBL] [Abstract][Full Text] [Related]
8. Antibiotic Resistance and Clinical Presentation of Health Care-Associated Hypervirulent
Hyun M; Lee JY; Ryu SY; Ryoo N; Kim HA
Microb Drug Resist; 2019 Oct; 25(8):1204-1209. PubMed ID: 31066617
[TBL] [Abstract][Full Text] [Related]
9. Increasing occurrence of antimicrobial-resistant hypervirulent (hypermucoviscous) Klebsiella pneumoniae isolates in China.
Li W; Sun G; Yu Y; Li N; Chen M; Jin R; Jiao Y; Wu H
Clin Infect Dis; 2014 Jan; 58(2):225-32. PubMed ID: 24099919
[TBL] [Abstract][Full Text] [Related]
10. Mapping the Evolution of Hypervirulent Klebsiella pneumoniae.
Struve C; Roe CC; Stegger M; Stahlhut SG; Hansen DS; Engelthaler DM; Andersen PS; Driebe EM; Keim P; Krogfelt KA
mBio; 2015 Jul; 6(4):e00630. PubMed ID: 26199326
[TBL] [Abstract][Full Text] [Related]
11. Infection with Carbapenem-resistant Hypervirulent Klebsiella Pneumoniae: clinical, virulence and molecular epidemiological characteristics.
Li L; Li S; Wei X; Lu Z; Qin X; Li M
Antimicrob Resist Infect Control; 2023 Nov; 12(1):124. PubMed ID: 37953357
[TBL] [Abstract][Full Text] [Related]
12. Nosocomial dissemination of hypervirulent
Du Q; Pan F; Wang C; Yu F; Shi Y; Liu W; Li Z; He P; Han D; Zhang H
Front Cell Infect Microbiol; 2022; 12():984180. PubMed ID: 36105148
[TBL] [Abstract][Full Text] [Related]
13. Emergence of Extensively Drug-Resistant and Hypervirulent KL2-ST65 Klebsiella pneumoniae Harboring
Liu C; Du P; Yang P; Yi J; Lu M; Shen N
Microbiol Spectr; 2022 Dec; 10(6):e0304422. PubMed ID: 36374105
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of Community-Acquired, Hypervirulent
Hao Z; Duan J; Liu L; Shen X; Yu J; Guo Y; Wang L; Yu F
Microb Drug Resist; 2020 Jan; 26(1):21-27. PubMed ID: 31408411
[TBL] [Abstract][Full Text] [Related]
15. [Investigation of Virulence Genes and Carbapenem Resistance Genes in Hypervirulent and Classical Isolates of Klebsiella pneumoniae Isolated from Various Clinical Specimens].
Yürek M; Cevahir N
Mikrobiyol Bul; 2023 Apr; 57(2):188-206. PubMed ID: 37067205
[TBL] [Abstract][Full Text] [Related]
16. High Prevalence of Hypervirulent Klebsiella pneumoniae Infection in China: Geographic Distribution, Clinical Characteristics, and Antimicrobial Resistance.
Zhang Y; Zhao C; Wang Q; Wang X; Chen H; Li H; Zhang F; Li S; Wang R; Wang H
Antimicrob Agents Chemother; 2016 Oct; 60(10):6115-20. PubMed ID: 27480857
[TBL] [Abstract][Full Text] [Related]
17. Isolation and characterization of a sequence type 25 carbapenem-resistant hypervirulent Klebsiella pneumoniae from the mid-south region of China.
Li J; Huang ZY; Yu T; Tao XY; Hu YM; Wang HC; Zou MX
BMC Microbiol; 2019 Sep; 19(1):219. PubMed ID: 31533609
[TBL] [Abstract][Full Text] [Related]
18. Characteristics of ST11 KPC-2-producing carbapenem-resistant hypervirulent Klebsiella pneumoniae causing nosocomial infection in a Chinese hospital.
Ouyang P; Jiang B; Peng N; Wang J; Cai L; Wu Y; Ye J; Chen Y; Yuan H; Tan C; Tan L; Xie L
J Clin Lab Anal; 2022 Jun; 36(6):e24476. PubMed ID: 35522153
[TBL] [Abstract][Full Text] [Related]
19. Emergence of Tigecycline Nonsusceptible and IMP-4 Carbapenemase-Producing K2-ST65 Hypervirulent Klebsiella pneumoniae in China.
Zhang Y; Wang X; Wang Q; Chen H; Li H; Wang S; Wang R; Wang H
Microbiol Spectr; 2021 Oct; 9(2):e0130521. PubMed ID: 34704778
[TBL] [Abstract][Full Text] [Related]
20. Hypervirulent Klebsiella pneumoniae (hypermucoviscous and aerobactin positive) infection over 6 years in the elderly in China: antimicrobial resistance patterns, molecular epidemiology and risk factor.
Liu C; Guo J
Ann Clin Microbiol Antimicrob; 2019 Jan; 18(1):4. PubMed ID: 30665418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
